114 related articles for article (PubMed ID: 31912488)
1. PFKFB4 negatively regulated the expression of histone acetyltransferase GCN5 to mediate the tumorigenesis of thyroid cancer.
Lu H; Chen S; You Z; Xie C; Huang S; Hu X
Dev Growth Differ; 2020 Feb; 62(2):129-138. PubMed ID: 31912488
[TBL] [Abstract][Full Text] [Related]
2. E2F2 drives glioma progression via PI3K/AKT in a PFKFB4-dependent manner.
Zhang L; Liu Z; Dong Y; Kong L
Life Sci; 2021 Jul; 276():119412. PubMed ID: 33774025
[TBL] [Abstract][Full Text] [Related]
3. KDM3A-mediated SP1 activates PFKFB4 transcription to promote aerobic glycolysis in osteosarcoma and augment tumor development.
Wang W; Wang B
BMC Cancer; 2022 May; 22(1):562. PubMed ID: 35590288
[TBL] [Abstract][Full Text] [Related]
4. CD44ICD promotes breast cancer stemness via PFKFB4-mediated glucose metabolism.
Gao R; Li D; Xun J; Zhou W; Li J; Wang J; Liu C; Li X; Shen W; Qiao H; Stupack DG; Luo N
Theranostics; 2018; 8(22):6248-6262. PubMed ID: 30613295
[TBL] [Abstract][Full Text] [Related]
5. PFKFB4 Promotes Breast Cancer Metastasis via Induction of Hyaluronan Production in a p38-Dependent Manner.
Gao R; Liu Y; Li D; Xun J; Zhou W; Wang P; Liu C; Li X; Shen W; Su W; Qiao H; Stupack DG; Luo N
Cell Physiol Biochem; 2018; 50(6):2108-2123. PubMed ID: 30415245
[TBL] [Abstract][Full Text] [Related]
6. 6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 acts as a protein kinase to regulate glioblastoma progression by activating the AKT/forkhead box O1 pathway.
Zhao K; Yu C; Luo J; Huang M; Wen Q; Zhao N
Acta Biochim Pol; 2022 Feb; 69(1):165-172. PubMed ID: 35143148
[TBL] [Abstract][Full Text] [Related]
7. Bruceine A induces cell growth inhibition and apoptosis through PFKFB4/GSK3β signaling in pancreatic cancer.
Zhang P; Tao W; Lu C; Fan L; Jiang Q; Yang C; Shang E; Cheng H; Che C; Duan J; Zhao M
Pharmacol Res; 2021 Jul; 169():105658. PubMed ID: 33992797
[TBL] [Abstract][Full Text] [Related]
8. PFKFB4 interacts with ICMT and activates RAS/AKT signaling-dependent cell migration in melanoma.
Sittewelle M; Kappès V; Zhou C; Lécuyer D; Monsoro-Burq AH
Life Sci Alliance; 2022 Aug; 5(12):. PubMed ID: 35914811
[TBL] [Abstract][Full Text] [Related]
9. Differential Effects of Histone Acetyltransferase GCN5 or PCAF Knockdown on Urothelial Carcinoma Cells.
Koutsogiannouli EA; Wagner N; Hader C; Pinkerneil M; Hoffmann MJ; Schulz WA
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28678170
[TBL] [Abstract][Full Text] [Related]
10. PFKFB4 Overexpression Facilitates Proliferation by Promoting the G1/S Transition and Is Associated with a Poor Prognosis in Triple-Negative Breast Cancer.
Cai YC; Yang H; Shan HB; Su HF; Jiang WQ; Shi YX
Dis Markers; 2021; 2021():8824589. PubMed ID: 34211613
[TBL] [Abstract][Full Text] [Related]
11. Long Noncoding RNA LINC003121 Inhibits Proliferation and Invasion of Thyroid Cancer Cells by Suppression of the Phosphatidylinositol-3-Kinase (PI3K)/Akt Signaling Pathway.
Min X; Liu K; Zhu H; Zhang J
Med Sci Monit; 2018 Jul; 24():4592-4601. PubMed ID: 29969438
[TBL] [Abstract][Full Text] [Related]
12. 6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells.
Ros S; Flöter J; Kaymak I; Da Costa C; Houddane A; Dubuis S; Griffiths B; Mitter R; Walz S; Blake S; Behrens A; Brindle KM; Zamboni N; Rider MH; Schulze A
Oncogene; 2017 Jun; 36(23):3287-3299. PubMed ID: 28092678
[TBL] [Abstract][Full Text] [Related]
13. Role of Akt/PKB and PFKFB isoenzymes in the control of glycolysis, cell proliferation and protein synthesis in mitogen-stimulated thymocytes.
Houddane A; Bultot L; Novellasdemunt L; Johanns M; Gueuning MA; Vertommen D; Coulie PG; Bartrons R; Hue L; Rider MH
Cell Signal; 2017 Jun; 34():23-37. PubMed ID: 28235572
[TBL] [Abstract][Full Text] [Related]
14. Coordinated expression of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 and heme oxygenase 2: evidence for a regulatory link between glycolysis and heme catabolism.
Li B; Takeda K; Ishikawa K; Yoshizawa M; Sato M; Shibahara S; Furuyama K
Tohoku J Exp Med; 2012 Sep; 228(1):27-41. PubMed ID: 22892400
[TBL] [Abstract][Full Text] [Related]
15. TRIM29 promotes progression of thyroid carcinoma via activating P13K/AKT signaling pathway.
Xu J; Li Z; Su Q; Zhao J; Ma J
Oncol Rep; 2017 Mar; 37(3):1555-1564. PubMed ID: 28098872
[TBL] [Abstract][Full Text] [Related]
16. Loss of PFKFB4 induces cell cycle arrest and glucose metabolism inhibition by inactivating MEK/ERK/c-Myc pathway in cervical cancer cells.
Wu Y; Zhang L; Bao Y; Wan B; Shu D; Luo T; He Z
J Obstet Gynaecol; 2022 Aug; 42(6):2399-2405. PubMed ID: 35659173
[TBL] [Abstract][Full Text] [Related]
17. Metabolic enzyme PFKFB4 activates transcriptional coactivator SRC-3 to drive breast cancer.
Dasgupta S; Rajapakshe K; Zhu B; Nikolai BC; Yi P; Putluri N; Choi JM; Jung SY; Coarfa C; Westbrook TF; Zhang XH; Foulds CE; Tsai SY; Tsai MJ; O'Malley BW
Nature; 2018 Apr; 556(7700):249-254. PubMed ID: 29615789
[TBL] [Abstract][Full Text] [Related]
18. Functional metabolic screen identifies 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 as an important regulator of prostate cancer cell survival.
Ros S; Santos CR; Moco S; Baenke F; Kelly G; Howell M; Zamboni N; Schulze A
Cancer Discov; 2012 Apr; 2(4):328-43. PubMed ID: 22576210
[TBL] [Abstract][Full Text] [Related]
19. PFKFB4 Drives the Oncogenicity in TP53-Mutated Hepatocellular Carcinoma in a Phosphatase-Dependent Manner.
Kam CS; Ho DW; Ming VS; Tian L; Sze KM; Zhang VX; Tsui YM; Husain A; Lee JM; Wong CC; Chan AC; Cheung TT; Chan LK; Ng IO
Cell Mol Gastroenterol Hepatol; 2023; 15(6):1325-1350. PubMed ID: 36806581
[TBL] [Abstract][Full Text] [Related]
20. PFKFB4 control of AKT signaling is essential for premigratory and migratory neural crest formation.
Figueiredo AL; Maczkowiak F; Borday C; Pla P; Sittewelle M; Pegoraro C; Monsoro-Burq AH
Development; 2017 Nov; 144(22):4183-4194. PubMed ID: 29038306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
